RDH11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.976600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.431000E-01
Normal-vs-Stage2
8.136400E-01
Normal-vs-Stage3
7.345200E-01
Normal-vs-Stage4
9.517000E-01
Stage1-vs-Stage2
4.209000E-01
Stage1-vs-Stage3
5.118400E-01
Stage1-vs-Stage4
7.422200E-01
Stage2-vs-Stage3
6.607400E-01
Stage2-vs-Stage4
8.713000E-01
Stage3-vs-Stage4
6.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.933200E-01
Normal-vs-AfricanAmerican
9.869000E-01
Normal-vs-Asian
8.004800E-01
Caucasian-vs-AfricanAmerican
9.837200E-01
Caucasian-vs-Asian
6.150200E-01
AfricanAmerican-vs-Asian
7.335800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.905000E-01
Normal-vs-Female
9.840000E-01
Male-vs-Female
9.023000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.580200E-01
Normal-vs-Age(41-60Yrs)
7.217400E-01
Normal-vs-Age(61-80Yrs)
8.471600E-01
Normal-vs-Age(81-100Yrs)
8.293000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.636200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.894600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.475400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.115900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.878000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.455600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.376800E-01
Normal-vs-Daily Drinker
5.752000E-01
Normal-vs-Weekly Drinker
4.905200E-01
Normal-vs-Occasional Drinker
7.510400E-01
Normal-vs-Social Drinker
8.379600E-01
Non Drinker-vs-Daily Drinker
7.211600E-01
Non Drinker-vs-Weekly Drinker
5.827600E-01
Non Drinker-vs-Occasional Drinker
1.610780E-01
Non Drinker-vs-Social Drinker
3.206000E-01
Daily Drinker-vs-Weekly Drinker
8.463000E-01
Daily Drinker-vs-Occasional Drinker
1.041850E-01
Daily Drinker-vs-Social Drinker
2.538600E-01
Weekly Drinker-vs-Occasional Drinker
9.815600E-02
Weekly Drinker-vs-Social Drinker
2.143000E-01
Occasional Drinker-vs-Social Drinker
8.918400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.749400E-01
Normal-vs-Grade 2
1.212160E-01
Normal-vs-Grade 3
1.771430E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.258400E-02
Grade 1-vs-Grade 3
4.814100E-02
Grade 1-vs-Grade 4
2.749400E-01
Grade 2-vs-Grade 3
5.371600E-01
Grade 2-vs-Grade 4
1.212160E-01
Grade 3-vs-Grade 4
1.771430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.061600E-01
Normal-vs-NonDiabetic
9.983600E-01
Diabetic-vs-NonDiabetic
2.464000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.635400E-01
Normal-vs-NoPancreatitis
9.595800E-01
Pancreatitis-vs-NoPancreatitis
1.174640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.457800E-01
Normal-vs-N1
8.546800E-01
N0-vs-N1
2.395400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.805000E-01
Normal-vs-TP53-NonMutant
7.832600E-01
TP53-Mutant-vs-TP53-NonMutant
2.839400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
